Take Face-to-Face Medicine to Digital: Omada Health CEO

The video discusses digital therapeutics, focusing on transitioning behavioral medicine from face-to-face to digital platforms. It highlights the Prevent program aimed at reducing type 2 diabetes risk through digital interventions. The program's features include social interaction and tracking tools. The company, backed by Andreessen Horowitz, plans to scale its operations while facing competition and challenges in the healthcare sector. The effectiveness of the program is demonstrated through published studies and transparent results.

What is the main idea behind digital therapeutics?

How does the digital program help individuals at high risk for type 2 diabetes?

What role do health coaches play in the digital therapeutic process?

What are some of the challenges faced by digital health entrepreneurs?

How can the success of the digital therapeutic programs be measured?

What is the significance of weight loss in relation to type 2 diabetes?

In what ways do successful participants influence others in their workplace?